European Medicines Agency - Regulatory - Regulation of medicines

4 - Quality management



    Description

Name

 

NIHR CRN-Children - National Institute for Health Research Clinical Research Network-Children

Documented adherence to GCP guideline Yes All studies within the MCRN Portfolio are conducted in compliance with the EU Directive 2001/20/EC on Clinical Trials. The MCRN has access to a comprehensive GCP training programme which is open to all investigators working on MCRN Portfolio studies.
Documented adherence to the ethical considerations for clinical trials in children Yes MCRN Portfolio studies comply with national and international ethical and research governance requirements.
Documented adherence to ethical considerations Yes Studies within the MCRN Portfolio are required to comply with UK ethics requirements.
Availability of Standard Operating Procedures (SOP) Yes MCRN Local Research Networks and the MCRN Clinical Trials Unit operate according to SOPs
Capacity to monitor studies
(academic trials industry sponsored trials)
No This is a core activity of the Clinical Trials Unit that work with the MCRN CC and LRNs/Areas to deliver studies. Other MCRN staff support activities on a case by case basis.
Capacity to monitor performance of collaborating centres Yes MCRN regional areas are closely performance monitored, with activity data reported to the MCRN Board and the Department of Health for England twice a year. Each MCRN Local Research Network is required to provide an annual report.
Quality control and quality assurance, raceability and data safety Yes This is a core activity of the Clinical Trials Unit that work with the MCRN CC and LRNs/Areas to deliver studies. Other MCRN staff support activities on a case by case basis.